Mergers & Acquisitions
Details of the mega-merger: Covidien makes the 1st move, Almeida prepares to step down
Congress moves to punish Medtronic and other ‘corporate deserters’
A handful of Democrats in Congress are hoping to curb a corporate exodus by threatening to withhold federal contracts from firms that shift their headquarters overseas to benefit from lower tax rates.
Medtronic, Covidien merger: Ishrak and Almeida go on tour
Hill-Rom closes $250M buyout of German OR infrastructure maker Trumpf
More mega-merger talk from medtech giants | MassDevice.com On Call
MASSDEVICE ON CALL — More medical device giants offered their 2¢ on high-dollar mega-mergers, joining other companies in saying that they aren’t planning any billion-dollar buys just yet.
Stryker closes portion of $375M Small Bone Innovations buy
Smith & Nephew CEO: We’ve been an M&A target for 10 years
Smith & Nephew (FTSE:SN, NYSE:SNN) isn’t in a big rush to jump on the mega-merger bandwagon, CEO Olivier Bohuon said today.
White House rails against Medtronic-style corporate inversions | MassDevice.com On Call
Baxter sheds vaccines biz for $635M
Report: Medtech M&A exits don’t hinge on FDA approval
The funding environment for medical device startups isn’t a pretty scene, but there is a ray of sunshine through the gloom: lack of FDA approval is no longer a deal-breaker for a big exit.
In 2013 a few medtech companies managed "big exit M&A" deals (those worth $50 million or more) without having reached the FDA’s brass ring, according to a new report from Silicon Valley Bank.